GlucoMe’s Decision Support System (“DSS”) personalizes treatment recommendations ensuring optimal oral drug intensification (2nd and 3rd line) for type 2 diabetes mellitus patients.

Digital diabetes solution provider, GlucoMe, announced today that it is exploring the expansion of its partnership with Merck KGaA, Darmstadt, Germany.

This follows a successful joint pilot in several Vietnam hospitals, facilitated by a third party.

Digital diabetes platform provider GlucoMe has entered into a pilot collaboration agreement with Merck KGaA, Darmstadt, Germany to evaluate GlucoMe’s digital diabetes platform across several hospitals in Vietnam.